A recent analysis found that 118 of 174 medical schools strictly restrict pharma rep access to physicians, and half apply that policy to their affiliated teaching hospitals. How can pharmaceutical brands reach these important doctors? BulletinHealthcare reaches more than 40,000 of these so-called “no see” physicians.
